Thymol analogues with antioxidant and L‐type calcium current inhibitory activity.
- Published in:
- Drug Development Research, 2005, v. 64, n. 4, p. 195, doi. 10.1002/ddr.10436
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2005 AND VI 64 AND IP 4
Results: 5
1
2
An innate immune regulatory factor (IIRF) prevents tumorogenesis in a murine melanoma challenge model.
- Published in:
- Drug Development Research, 2005, v. 64, n. 4, p. 213, doi. 10.1002/ddr.10434
- By:
- Publication type:
- Article
3
Pharmacogenomics in sepsis and septic shock.
- Published in:
- Drug Development Research, 2005, v. 64, n. 4, p. 181, doi. 10.1002/ddr.10433
- By:
- Publication type:
- Article
4
Quantitative structure–activity relationship studies of cyclooxygenase inhibitors: a comprehensive analysis.
- Published in:
- Drug Development Research, 2005, v. 64, n. 4, p. 220, doi. 10.1002/ddr.10432
- By:
- Publication type:
- Article
5
Novel estrogen receptor ligands and their structure–activity relationship evaluated by scintillation proximity assay for high‐throughput screening.
- Published in:
- Drug Development Research, 2005, v. 64, n. 4, p. 203, doi. 10.1002/ddr.10435
- By:
- Publication type:
- Article